In metabolic-associated steatotic liver disease models, deficiency of Saa1/Saa2 in mice due to genetic KO or shRNA knockdown ameliorates steatohepatitis, suggesting that SAA is pathogenic in high-fat diet–induced liver disease. Here, SAA2 is linked to liver disorder.